We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-15.26%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$7.53B
AUM Growth
-$2.75B
Cap. Flow
-$1.08B
Cap. Flow %
-14.29%
Top 10 Hldgs %
12.34%
Holding
1,547
New
122
Increased
288
Reduced
505
Closed
182

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$67.4M
2
UNP icon
Union Pacific
UNP
+$58.9M
3
LLY icon
Eli Lilly
LLY
+$58.2M
4
MKC icon
McCormick & Company Non-Voting
MKC
+$55.5M
5
PLD icon
Prologis
PLD
+$44.7M

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$86.6M
2
DINO icon
HF Sinclair
DINO
+$82.3M
3
CAT icon
Caterpillar
CAT
+$75.6M
4
FANG icon
Diamondback Energy
FANG
+$65.1M
5
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$59.8M

Sector Composition

Rank Sector Weight
1 Financials 24.04%
2 Healthcare 13.43%
3 Consumer Discretionary 11.21%
4 Industrials 10.14%
5 Technology 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LFCR icon
1226
Lifecore Biomedical
LFCR
$167M
$189K ﹤0.01%
16,000
-9,900
-38% -$136K
MBIO icon
1227
Mustang Bio
MBIO
$4.52M
$184K ﹤0.01%
83
-17
-17% -$51.7K
ENSV
1228
DELISTED
Enservco Corp.
ENSV
$184K ﹤0.01%
33,073
– –
ALYA
1229
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$183K ﹤0.01%
+78,063
New +$291K
VTVT icon
1230
vTv Therapeutics
VTVT
$135M
$182K ﹤0.01%
1,720
– –
AAME icon
1231
Atlantic American Corp
AAME
$31.6M
$181K ﹤0.01%
74,856
– –
HHS icon
1232
Harte-Hanks
HHS
$16.8M
$181K ﹤0.01%
74,800
+25,000
+50% +$119K
HSTO
1233
DELISTED
Histogen Inc. Common Stock
HSTO
$179K ﹤0.01%
517
-165
-24% -$128K
SSI
1234
DELISTED
Stage Stores Inc
SSI
$179K ﹤0.01%
242,100
– –
AXSM icon
1235
Axsome Therapeutics
AXSM
$11B
$178K ﹤0.01%
63,000
-25,000
-28% -$82.3K
SPRO icon
1236
Spero Therapeutics
SPRO
$73M
$176K ﹤0.01%
28,579
-50,000
-64% -$405K
SVT
1237
DELISTED
Servotronics
SVT
$176K ﹤0.01%
17,653
– –
SYBX
1238
DELISTED
Synlogic
SYBX
$175K ﹤0.01%
1,667
-3,474
-68% -$457K
JBLU icon
1239
JetBlue
JBLU
$2.4B
$172K ﹤0.01%
10,700
– –
DZSI
1240
DELISTED
DZS Inc. Common Stock
DZSI
$171K ﹤0.01%
+12,300
New +$166K
SFE
1241
DELISTED
Safeguard Scientifics, Inc.
SFE
$168K ﹤0.01%
19,500
– –
CBL
1242
DELISTED
CBL& Associates Properties, Inc.
CBL
$168K ﹤0.01%
87,600
-315,400
-78% -$925K
WIN
1243
DELISTED
Windstream Holdings Inc
WIN
$167K ﹤0.01%
79,960
-53,680
-40% -$200K
LWAY icon
1244
Lifeway Foods
LWAY
$449M
$166K ﹤0.01%
88,052
– –
PDLB icon
1245
Ponce Financial Group
PDLB
$495M
$166K ﹤0.01%
+18,135
New +$174K
AAC
1246
DELISTED
AAC Holdings
AAC
$166K ﹤0.01%
118,300
– –
FCEL icon
1247
FuelCell Energy
FCEL
$1.69B
$165K ﹤0.01%
+833
New +$238K
ZYNE
1248
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$165K ﹤0.01%
55,500
– –
UONEK icon
1249
Urban One Class D
UONEK
$24.8M
$164K ﹤0.01%
10,180
– –
AP icon
1250
Ampco-Pittsburgh
AP
$192M
$159K ﹤0.01%
51,400
+4,017
+8% +$16.9K
48 49
50
51 52

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Bridgeway Capital Management held 1,547 positions worth $7.53B, down 27% from $10.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bridgeway Capital Management withdrew a net $1.08B in Q4 2018, closing 182 positions and reducing 505 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $86.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Bridgeway Capital Management opened a new position in Eli Lilly worth $60.3M.

  • Bridgeway Capital Management's largest Q4 2018 buy was Eli Lilly: 521,450 shares worth $60.3M.
  • Bridgeway Capital Management added most to Merck in Q4 2018, an estimated $67.4M increase.
  • Bridgeway Capital Management's biggest Q4 2018 reduction was ON Semiconductor, cutting an estimated $54.9M.
  • Bridgeway Capital Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $86.6M.
  • Bridgeway Capital Management's ten largest holdings make up 12% of its $7.53B portfolio in Q4 2018.
  • Bridgeway Capital Management opened 122 new positions and closed 182 in Q4 2018.
  • Bridgeway Capital Management's portfolio value fell 27% quarter-over-quarter to $7.53B.

Based on Bridgeway Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.